The Neural Cell Adhesion Molecule (NCAM) Promotes Clustering and Activation of EphA3 Receptors in GABAergic Interneurons to Induce Ras Homolog Gene Family, Member A (RhoA)/Rho-associated protein kinase (ROCK)-mediated Growth Cone Collapse by Sullivan, Chelsea S. et al.
The Neural Cell Adhesion Molecule (NCAM) Promotes
Clustering and Activation of EphA3 Receptors in GABAergic
Interneurons to Induce Ras Homolog Gene Family, Member A
(RhoA)/Rho-associated protein kinase (ROCK)-mediated
Growth Cone Collapse*
Received for publication, September 22, 2016, and in revised form, October 24, 2016 Published, JBC Papers in Press,November 1, 2016, DOI 10.1074/jbc.M116.760017
Chelsea S. Sullivan, Maike Kümper, Brenda S. Temple, and Patricia F. Maness1
From the Department of Biochemistry and Biophysics, R. L. Juliano Structural Bioinformatics Core, School of Medicine, University of
North Carolina, Chapel Hill, North Carolina 27599-7264
Edited by F. Anne Stephenson
Establishment of a proper balance of excitatory and inhibitory
connectivity is achieved during development of cortical networks
and adjusted through synaptic plasticity. The neural cell adhesion
molecule (NCAM) and the receptor tyrosine kinase EphA3 regu-
late the perisomatic synapse density of inhibitory GABAergic
interneurons in the mouse frontal cortex through ephrin-A5-in-
ducedgrowthconecollapse. In this study, itwasdemonstrated that
binding of NCAM and EphA3 occurred between the NCAM Ig2
domain and EphA3 cysteine-rich domain (CRD). The binding
interface was further refined through molecular modeling and
mutagenesis and shown to be comprised of complementary
charged residues in theNCAMIg2 domain (Arg-156 and Lys-162)
and the EphA3 CRD (Glu-248 and Glu-264). Ephrin-A5 induced
co-clustering of surface-bound NCAM and EphA3 in GABAergic
cortical interneurons in culture. Receptor clustering was impaired
by a charge reversal mutation that disrupted NCAM/EphA3
association, emphasizing the importance of the NCAM/EphA3
binding interface for cluster formation. NCAM enhanced ephrin-
A5-induced EphA3 autophosphorylation and activation of RhoA
GTPase, indicating a role forNCAMin activatingEphA3 signaling
through clustering. NCAM-mediated clustering of EphA3 was
essential for ephrin-A5-induced growth cone collapse in cortical
GABAergic interneurons, andRhoA and a principal effector, Rho-
associated protein kinase, mediated the collapse response. This
study delineates a mechanism in which NCAM promotes ephrin-
A5-dependent clustering of EphA3 through interaction of the
NCAMIg2 domain and the EphA3CRD, stimulating EphA3 auto-
phosphorylation and RhoA signaling necessary for growth cone
repulsioninGABAergic interneurons invitro,whichmayextendto
remodeling of axonal terminals of interneurons in vivo.
Neural cell adhesionmolecule (NCAM)2 is a key regulator of
cell adhesion, axon growth, and fasciculation (1). NCAM also
plays a critical role in the regulation of perisomatic synapses in
the developing prefrontal cortex (2). For information to be
transmitted effectively within the brain, an intricate balance of
excitation and inhibition in the cortical circuitrymust be estab-
lished. Because inhibitory synapses perform essential roles in
network function (3–7), the elucidation of how they are pro-
duced and refined is of vital importance. Inhibitory GABAergic
synapses make and break connections in response to activity-
dependent and -independent stimuli throughout development
and into adulthood in a dynamic manner (6–9). Alterations of
inhibition disrupt the excitation and inhibition balance and
are associated with cognitive deficits in schizophrenia (10–
12) and autism (13–16). Although the mechanisms regulat-
ing formation and fine-tuning of excitatory synapses have
been extensively studied (17, 18), the molecular pathways
underlying inhibitory synapse formation and refinement are
poorly understood.
Previous work identified a novel role for the neural adhesion
molecule NCAM as an obligate component of a receptor com-
plex that acts in the early postnatal mousemedial frontal cortex
to constrain basket interneuron connectivity with pyramidal
neuron soma (2). Deletion of NCAM, EphA3, or ephrin-A2/
A3/A5 in mice increases the number of perisomatic basket cell
synaptic terminals in the mPFC (2). NCAM associates with
EphA3 tyrosine kinase, an ephrin-A5 receptor, and mediates
growth cone collapse of GABAergic interneuron terminals in
cortical neuron cultures (2). Furthermore, ephrin-A5 treat-
ment of cortical slices promotes loss of perisomatic basket cell
synaptic puncta, and this loss is NCAM-dependent (2).
Although NCAM and EphA3 co-localize in vivo at perisomatic
synapses (2), the significance andmechanismofNCAM/EphA3
binding and clustering are not understood. Highlighting the
importance of NCAM and ephrinA/EphA signaling in human
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cortical circuitry, genetic polymorphisms and dysregulation of
NCAM (19–25) or EphA/ephrinA (26–28) are associated with
schizophrenia, autism, and bipolar disorder.
EphA3 kinase activation and signaling depend on receptor
clustering and are important for growth cone collapse, axon
repulsion, and synaptic plasticity (29). The extracellular do-
main of EphA receptors consists of a ligand-binding domain
(LBD), a cysteine-rich domain (CRD), and two fibronectin III
(FN) domains (30). Crystallographic studies of ephrin-A5 or
ephrin-A2 bound EphA2 demonstrated that ephrinA-EphA
interactions are mediated by the LBD and an additional surface
in the CRD, enabling formation of large multimeric receptor/
ligand clusters. Studies of EphA4 clustering suggested that only
the CRD interface is important for clustering of EphA4, rather
than the additional LBD interface used by EphA2 (31).
Together, these studies indicate that even Eph receptors in the
same family can have varying clustering properties based on
subtle differences in their ectodomains. The EphA3 structure
has not been solved, but its overall sequence is more similar to
EphA4 than EphA2.
HowNCAM engages EphA3 to promote repellent responses
is unclear. NCAM has five Ig-class and two FN domains in its
extracellular region and a cytoplasmic domain that differs in
size among three principal isoforms (32). The NCAM extracel-
lular region can be modified by polysialylation (PSA-NCAM),
which is implicated in mediating synaptic plasticity (33). PSA-
NCAMis highly expressed in the embryonic and early postnatal
stages and in interneuron populations in the mature cortex
(33–36). The 140-kDa isoform NCAM140 interacts physically
and functionally with EphA3 to a greater extent than other iso-
forms (2) and is most prominent in axonal growth cones of
developing neuronal cells (37). NCAM forms trans and cis
homodimers in the plasma membrane, and these interactions
aremediated by the Ig1, Ig2, and Ig3 domains as well as the first
FN domain (32, 38). Based on the knowledge that NCAM and
EphA3 colocalize at perisomatic synapses in vivo, interact bio-
chemically, and promote remodeling of GABAergic interneu-
ron terminals (2), we hypothesized that NCAM may promote
EphA3 receptor clustering and signaling to bring about growth
cone collapse and axon terminal retraction.
In this study, we utilized an approach combining molecular
modeling based on crystal structures of rat NCAM Ig1–3 (PDB
code 1QZ1) and the LBD/CRD regions of human EphA4 (PDB
code 4M4P), analysis of receptor clustering, and functional
assays to define themolecular and cellularmechanismbywhich
NCAM promotes EphA3 signaling required for growth cone
collapse of GABAergic interneurons. It was demonstrated that
NCAM binding to EphA3 promotes ephrin-A5-dependent
receptor clustering to activate EphA3 kinase signaling, nec-
essary for EphA3 autophosphorylation, RhoA-GTPase acti-
vation, and growth cone collapse of cortical GABAergic
interneurons.
Results
The Ig2 Domain of NCAMBinds the Cysteine-rich Domain of
EphA3 through a Charged Interface—Previous studies identi-
fied an interaction between NCAM and EphA3 in the mouse
forebrain, and the interaction site onNCAMwasmapped to the
extracellular region (2).Wehypothesized thatNCAMmay pro-
mote receptor clustering and signaling by binding EphA3
through association with specific extracellular domains. To
identify the binding determinants on EphA3 and NCAM, pull-
down experiments were performed using domain deletions of
each molecule. HEK293T cells were transfected with WT
EphA3, EphA3 lacking the LBD (EphA3LBD), and EphA3
lacking both the LBD and CRD (EphA3LBD/CRD) (39).
Transfected lysates were incubated with purified fusion pro-
teins consisting of the entire extracellular region of NCAM,
Ig1–5/FN1–2 with a C-terminal Fc tag (NCAM-EC). Protein
A/G-Sepharose pulldown of NCAM-EC showed that the
extracellular domain of NCAM bound WT EphA3 and
EphA3LBD, indicating that the ligand-binding domain
of EphA3 was not required for interaction with NCAM. How-
ever, EphA3LBD/CRD was unable to bind NCAM-EC (Fig.
1B), identifying the CRD as the critical binding domain. To
delineate the EphA3 binding domain on NCAM, full-length
NCAM-EC or NCAM truncations containing Ig1–3, Ig1–2,
Ig2, or Ig1 as Fc fusion proteins were incubated with lysates of
HEK293T cells transfected with WT EphA3. Fc pulldown
assays showed that NCAM Ig1–3, Ig1–2, and the Ig2 domain
alone bound EphA3, whereas NCAM Ig1 was not sufficient for
binding (Fig. 1,C andD). These experiments demonstrated that
the Ig2 domain of NCAMcontains the required binding site for
EphA3.
To more finely map the interaction determinants at the
amino acid level, molecular modeling was performed using the
ClusPro server (40) to analyze docking between rat NCAM
Ig1–3 (PDB code 1QZ1) (38) and mouse EphA3 LBD/CRD
modeled on human EphA4 (PDB code 4M4P) (41). Docking
poses were screened for compatibility with interaction on the
surface of a membrane in a cis conformation, lack of steric hin-
drance between additional domains of the molecules, and the
number of hydrogen bonds within the interaction interface.
Structural modeling suggested that NCAM and EphA3 bind
through a charged interface involving basic residues in the
NCAM Ig2 domain (Arg-156, Lys-162, and Arg-192) engaging
acidic residues of the EphA3 CRD (Glu-246, Glu-248, and Glu-
264) (Fig. 1A). To test thismodel, site-directedmutagenesiswas
used to generate charge reversal mutants of NCAM and EphA3
at the predicted sites of interaction. The mutations NCAM
R156E and K162D decreased binding to EphA3 to levels of 11%
and 10% of the WT, respectively (Fig. 1, E and F; p  0.05).
Interestingly, these two basic residues were located in the hep-
arin binding site of the Ig2 domain, KHKGRDVILKKDVRFI
(42). The heparin binding sites are solvent-exposed in NCAM
dimers, suggesting that NCAMmay engage in homophilic and
heterophilic binding concurrently. This motif is also important
for binding to extracellular matrix proteoglycans (43). NCAM
R192E exhibited diminished binding to EphA3, although the
decrease did not reach significance (p 0.065). Arg-192 is con-
tained in the sequence GRILARGEINFK of the NCAM Ig2
domain that is required for binding to Ig1 necessary forNCAM-
NCAM homodimerization (44). Charge reversal mutations in
predicted interaction sites of EphA3 (E248R or E264K) signifi-
cantly inhibited co-immunoprecipitation of EphA3 andNCAM
(2%of theWT) (Fig. 1,G andH). Together, thesemutagenesis
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experiments demonstrate that the Ig2 domain of NCAM and
the CRD domain of EphA3 comprise a charged interface for
interaction.
NCAMBinding EphA3Promotes Ephrin-A5-dependentClus-
tering of Receptors inCorticalGABAergic Interneurons—EphA3
signaling depends on ligand-induced receptor clustering and is
important for growth cone collapse, axon repulsion, and synap-
tic plasticity (45, 46). Studies of EphA family members demon-
strated that EphA2 forms extended arrays through two distinct
interfaces (47) in the LBD and CRD, whereas EphA4 clusters
are typically smaller and oligomeric because of their reliance on
only one of these two corresponding interfaces, the CRD inter-
face, suggesting that EphA receptors can have different cluster-
ing tendencies based on their ectodomains (31). However, the
extent to which these clusters form in the absence of NCAM is
not known.
The importance of NCAM/EphA3 binding for receptor clus-
teringwas assessed in cortical neuron cultures fromNCAMKO
mice co-transfected with WT or mutant NCAM140 together
with pCMV-IRES-eGFP (Fig. 2A). We focused on GABAergic
(GABA-immunopositive) interneurons in these cultures based
on the identified role of NCAM at interneuron perisomatic
puncta. After treatment with preclustered Fc or ephrin-A5-Fc
for 30 min, cells were immunostained for GABA, NCAM, and
EphA3 and imaged confocally. GFP/GABA double-positive
cells were selected in single optical sections, and colocalization
of NCAMand EphA3was assessed. GABA staining allowed the
identification of individual axons to ensure that clustering was
observed in single neurites and not bundles.
The proportion of colocalized signal for each channel was
evaluated by colocalization analysis yielding thresholded
Manders coefficients (Fig, 2, B and C; tM1, proportion of red
pixels colocalizing with green pixels; tM2, proportion of green
pixels colocalizing with red pixels). As a further measure of
correlation of the two fluorescent signals, Pearson correlation
coefficients (R  0 indicates positive correlation, R  0 indi-
cates negative correlation) were generated (Fig. 2D). Ephrin-
A5-Fc strongly promoted colocalization/clustering of WT
NCAM and EphA3 compared with control Fc, as shown by
merged fluorescent images, heat maps of colocalization, and
colocalization coefficients (Fig. 2). Ephrin-A5-Fc also pro-
moted EphA3 colocalization withNCAMR192E, amutant that
did not disrupt association of NCAM and EphA3. On the other
hand, ephrin-A5-Fc did not promote colocalization of EphA3
with NCAMR156E. These colocalization analyses were consis-
tent with co-immunoprecipitation studies that showed interac-
tion of EphA3 with WT NCAM and NCAM R192E but not
NCAM R156E (Fig. 1, E and F). The results demonstrate that
binding of NCAM to EphA3 promotes ephrin-A5-dependent
clustering of receptors in cortical GABAergic interneurons.
NCAM Binding EphA3 Is Required for Ephrin-A5-induced
Growth Cone Collapse—Growth cone collapse is a widely used
paradigm for assessment of ephrin-A5-repellent responses in
developing axons and for identifying modulators of ephrin-A5
signaling in vitro (48–50). To assess the function of NCAM Ig2
interaction with the EphA3 CRD in growth cone collapse,
NCAM KO cortical neuron cultures were co-transfected with
empty vector (pCDNA3.1), WT NCAM, or NCAM mutants
(R192E and R156E) together with pCMV-IRES-eGFP. After
48 h, cells were treated with preclustered Fc or ephrin-A5-Fc
for 30 min. Cultures were fixed and immunostained for GABA
and GFP to identify transfected interneurons. Growth cones
were visualized by GABA staining and scored as collapsed
(Fig. 3A, arrowheads) or spread (Fig. 3A, arrows) as described
FIGURE 1. The EphA3 CRD binds the NCAM Ig2 domain. A, a candidate pose of Ig1-Ig3 of NCAM docked with LBD-CRD of EphA3. The predicted interface is
labeled with arrows. B, Fc pulldowns of NCAM-EC and EphA3 or EphA3 deletion mutants. C, Fc pulldowns of NCAM-EC or truncation mutants and EphA3. D,
densitometry of C. The amount of bound EphA3 for each Fc protein was normalized to control NCAM-EC-bound EphA3 (n 3; *, p 0.05). E, co-immunopre-
cipitation (IP) of WT NCAM or mutants of NCAM and EphA3 from transfected HEK293T cells. IB, immunoblot. F, densitometry of E. The amount of co-
immunoprecipitated EphA3 for each NCAM immunoprecipitation was normalized to control WT NCAM-bound EphA3 (n 3; *, p 0.05). G, co-immunopre-
cipitation of NCAM andWT EphA3 or EphA3mutants from transfected HEK293T cells. H, densitometry of G. The amount of co-immunoprecipitated EphA3 for
eachNCAM immunoprecipitationwas normalized to controlWT EphA3 (n 3; *, p 0.05). Student’s t testwas performed for each of the binding experiments.
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previously (2), and only GFP-positive (transfected) cells were
included in the analysis.
Neurons expressing WT-NCAM exhibited robust growth
cone collapse in response to ephrin-A5-Fc, consistent with a
requirement for NCAM in ephrin-A5-mediated growth cone
collapse (Fig. 3) as observed previously (2). NCAMKOneurons
transfected with empty vector did not undergo significant
growth cone collapse after ephrin-A5-Fc treatment. In con-
trast, the R156E mutant of NCAM that was unable to bind or
cluster EphA3 was not effective in promoting growth cone col-
lapse in response to ephrin-A5-Fc (Fig. 3). The NCAM R192E
mutant, which did not showdecreased binding to EphA3, effec-
tively promoted growth cone collapse. These functional studies
support a role for EphA3 and NCAM binding in ephrin-A5-
induced growth cone collapse of GABAergic interneurons.
NCAMEnhances EphA3Autophosphorylation in Response to
Ephrin-A5inCorticalNeurons—Ligand-dependentEphA3olig-
omerization promotes activation of its kinase domain and
induces autophosphorylation of EphA3 and transphosphoryla-
tion of tyrosine residues in the cytoplasmic domain (51, 52).
Because NCAM binding to EphA3 enhanced clustering in cor-
tical neurons, we hypothesized that NCAM promotes EphA3
kinase activation and downstream signaling. EphA3 autophos-
phorylation was assessed in cortical neuron cultures fromWT
FIGURE 2. Ephrin-A5 induces clustering of NCAMand EphA3 in cortical interneurons. A, NCAMKO cortical neuronswere co-transfectedwithWTNCAMor
NCAMmutants andpCAG-IRES-EGFP. Cellswere treatedwithpreclusteredFcor ephrin-A5-Fc, and localizationofNCAM(pseudocoloredgreen) andEphA3 (red)
was assessed by confocalmicroscopy. Axons of GABA-immunoreactive interneuronswere imaged, and colocalization of NCAMand EphA3was assessed using
ImageJ to generate a heat map of colocalization (fourth column). Scale bar 5 M. Thresholded Manders coefficients (tM1, B; tM2, C) and Pearson correlation
coefficients (R-Total, D) were generated using ImageJ colocalization software (n 3; *, p 0.05; n.s., not significant; Student’s t test was performed between
Fc and ephrinA5-Fc treated cells for each vector).
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and NCAMKOmice after treatment with preclustered control
Fc or ephrin-A5-Fc. EphA3 was immunoprecipitated and
subjected to immunoblotting with phosphotyrosine antibody
(Tyr(P)-99), followed by stripping and reprobing for total
EphA3. The ratio of phospho-EphA3 to total EphA3 was quan-
tified by densitometry and compared for significant differences.
InWT cultures, ephrin-A5-Fc promoted robust tyrosine phos-
phorylation of EphA3 (Fig. 4A). In contrast, NCAM KO cul-
tures treated with ephrin-A5-Fc exhibited no increased phos-
phorylation compared with Fc controls, indicating that NCAM
was required for activation and autophosphorylation of EphA3
kinase.
NCAM-dependent Activation of RhoA GTPase and ROCK Is
Required for Ephrin-A5-dependent Growth Cone Collapse—To
assess the role of Rho family GTPases in NCAM/EphA3 signal-
ing, the activation of RhoA,Cdc42, andRac1 in cortical neurons
was determined by measuring GTP-bound GTPase levels in
pulldown assays. Cortical neurons were stimulated with Fc or
ephrin-A5-Fc and lysed, and GTP-bound GTPases were pulled
down using GST-tagged effector proteins conjugated to gluta-
thione-Sepharose beads (GST-Pak binding domain (PBD) for
Rac1 andCdc-42, GST-Rho binding domain of Rhotekin (RBD)
for RhoA). The ratio of active (GTP-bound) RhoA, Rac1, or
Cdc-42 to inputwas determined for each condition (Fc- or eph-
rin-A5-Fc-treated) andnormalized to Fc-treated cells (n 3 for
each GTPase). In WT neurons, GTP-bound RhoA increased
5-fold in response to ephrin-A5-Fc, whereas the levels of GTP-
bound Rac1 and Cdc-42 were not significantly altered upon
treatment (Fig. 5, A and B). In contrast, NCAM KO neurons
showed no increase in GTP-bound RhoA upon stimulation
with ephrin-A5-Fc, indicating a requirement for NCAM in
ephrin-A5-dependent RhoA activation (Fig. 5, A and B).
To determine whether RhoA activation promoted growth
cone collapse in cortical GABAergic interneurons treated with
ephrin-A5-Fc, cortical neuron cultures were pretreated with
the RhoA inhibitor exoenzyme C3 transferase prior to stimula-
tionwith preclustered Fc or ephrin-A5-Fc. Pretreatment ofWT
neuronswithC3 toxin strongly inhibited ephrin-A5-dependent
growth cone collapse in comparison with ephrin-A5-treated
cells without C3 pretreatment (two-way ANOVAwith Bonfer-
roni post hoc testing, p 0.001).
The role of RhoA signaling in ephrin-A5-dependent growth
cone collapse was further evaluated by inhibition of ROCK1/2,
a key downstream effector of RhoA. Cortical neurons were pre-
treatedwith Y-27632, a selective inhibitor of ROCK1/2, prior to
stimulation with preclustered Fc or ephrin-A5-Fc, and GABA-
positive interneurons were assayed for growth cone collapse.
ROCK inhibition significantly decreased the percent of
GABAergic cells exhibiting growth cone collapse upon ephrin-
A5-Fc treatment compared with cells without Y-27632 pre-
treatment (two-way ANOVAwith Bonferroni post hoc testing,
p 0.001). These results supported the conclusion that ephrin-
A5-induced growth cone collapse in GABAergic interneurons
is dependent on RhoA and its effector ROCK1/2.
Discussion
Anovel role forNCAM in clustering and activation of EphA3
receptors necessary for axonal repellent responses in cortical
neurons was identified using a combination of molecular
modeling, mutagenesis, and functional assays. These studies
revealed for the first time that NCAM promotes EphA3 recep-
tor clustering in response to ephrin-A5 stimulation through
binding between critical determinants in the NCAM Ig2 and
EphA3 CRD domains. Although direct binding of NCAM and
EphA3 was not demonstrated, molecular modeling and the
effects of charge reversal mutations suggested that the interac-
tion was likely to be direct. This interaction induced NCAM/
EphA3 clustering, EphA3 kinase activation, and growth cone
collapse of GABAergic interneurons stimulated by the ligand
ephrin-A5. Downstream signaling through RhoA GTPase and
one of its principal effectors, ROCK1/2, mediated the collapse
response (Fig. 6). This molecular mechanism, as delineated in
cortical neuron cultures, may also be important in regulating
the density of axonal terminals of GABAergic interneurons in
the developing neocortex.
Domain truncation analysis demonstrated that the associa-
tion between NCAM and EphA3 was mediated by the NCAM
Ig2 domain and EphA3 CRD. An interface involving comple-
mentary charged residues in the interacting domains was pre-
dicted from molecular modeling and shown by mutagenesis to
be critical for association. Charge reversal mutations in either
FIGURE 3.NCAM binding to EphA3 promotes ephrin-A5-induced growth
cone collapse in GABAergic interneurons. A, NCAM KO neurons were co-
transfected with empty vector, WT NCAM, or mutant NCAM together with
pCAG-IRES-EGFP and stained for GFP and GABA. Representative images of
GABA-positive interneurons (DIV 12) treated with preclustered control Fc or
ephrin-A5-Fc and stained for GABA are shown. Spread growth cones are indi-
cated with arrows, and collapsed growth cones are marked with arrowheads.
Scale bars  10 M and 2.5 M in the magnified insets. B, the percentage of
collapsed growth coneswas determined (300 growth cones/condition; n 3
experiments; *, p 0.05; n.s., not significant). Student’s t test was performed
between Fc- and ephrinA5-Fc-treated cells for each vector.
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of two basic residues of NCAM Ig2 (R156E and K162D) located
in the predicted interface disrupted EphA3 binding. Mutation
of either corresponding acidic residue in the EphA3 CRD (Glu-
248 and Glu-264) predicted to bind the basic residues blocked
the NCAM interaction. In contrast, mutation of R192E in the
NCAM Ig2 domain did not significantly perturb EphA3 associ-
ation. This residue was located within the amino acid sequence
GRILARGE, amotif required for NCAM-NCAMdimerization.
Interestingly, the basic residues in NCAM Ig2 (R156E and
K162D) mediating EphA3 association were positioned within
the heparin-binding site, which is essential for interaction of
NCAM with extracellular matrix proteoglycans. It is possible
that EphA3 binding to NCAM at the heparin-binding site may
disrupt cell matrix adhesion as a necessary step for retraction of
axon terminals.
Crystallographic studies of closely related EphA2 and EphA4
receptors identified a leucine zipper-like interface in the CRD
comprised of hydrophobic residues that mediates EphA clus-
tering in the plasma membrane (31, 41, 47, 53) and an addi-
tional LBD interface that promotes large-scalemultimerization
of EphA2 (31, 47, 53). EphA3 has not been crystallized, but the
LBD interface involved in EphA2 dimerization is highly con-
served in EphA3 (31). The predicted NCAM Ig2/EphA3 inter-
face is sterically compatible with NCAMbinding to the CRD of
a dimer of EphA3 interacting through the LBD/LBD interface.
It can be speculated that NCAM further enhances the higher-
order clustering of EphA3 receptors by side-to-side interac-
tions between the NCAM Ig2 domain and EphA3 CRD. This
interaction may involve NCAM dimers, which likely form
through Ig1-Ig2 cis interactions implicated in the crystal struc-
ture of NCAM Ig1–3 (38) (Fig. 6). NCAM forms cis and trans
homodimers (32), but results strongly suggest that trans inter-
actions of NCAM are not essential for EphA3 clustering. Func-
tional assays of receptor clustering and growth cone collapse
were done in NCAM-null cells transfected with NCAM. As
individual transfected cells were analyzed, there would be few,
if any, NCAM trans homodimers formed through contact with
adjacent untransfected cells (which lack NCAM). Molecular
modeling studies of NCAM/EphA3 were consistent with cis
interactions, and trans interactions would likely occur through
a different interface because of the altered orientation of the N
and C termini of receptors on opposing cells.
In addition, theNCAMcytoplasmic domain directly engages
the actin cytoskeleton through spectrin binding (54), which
FIGURE 4.NCAMstimulates EphA3 autophosphorylation in response to ephrin-A5 treatment in cortical neurons. A, cortical neuron cultures fromWT or
NCAMKOmice (DIV 12) were treatedwith preclustered control Fc or ephrin-A5-Fc, and EphA3was immunoprecipitated (IP). EphA3 autophosphorylationwas
assessed using phosphotyrosine antibodies, and total levels of immunoprecipitated EphA3were assessed by reprobingwith EphA3 antibody. IB, immunoblot.
B, densitometry of A. The graph indicates the ratio of phosphotyrosine to EphA3 values for each condition (n 3; *, p 0.05; n.s., not significant). Student’s t
test was performed between Fc- and ephrinA5-Fc-treated cells for each genotype.
FIGURE 5.NCAM-dependent EphA3 activation promotes activation of RhoA, required for growth cone collapse. A, activation of RhoA, Rac1, and Cdc42
was assessed in WT or NCAM KO cultures after treatment with preclustered ephrin-A5-Fc or control Fc. B, densitometry of active RhoA (in WT and NCAM KO
cultures), Rac1 (WT), and Cdc42 (WT) normalized to control Fc. The graph shows mean with S.E. A two-way ANOVA with Bonferroni post hoc testing was
performed between NCAM KO andWT cells for RhoA activation after Fc or ephrinA5-Fc treatment (***, p 0.001). For Cdc42 and Rac1 activation in WT cells,
Student’s t testwasperformedbetweenFc- andephrinA5-Fc-treated cells for eachGTPase.C, growth cone collapseofWTneuronspretreatedwithC3, Y-27632,
or control untreated and preclustered Fc or ephrin-A5-Fc. The graph shows mean with S.E., two-way ANOVA with Bonferroni post hoc testing (n  3
experiments;500 growth cones/condition; ***, p 0.001).
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may stabilize clusters of EphA receptors that are sensitive to
adhesive force (55). Clustering of Eph receptors is critical for
activating ephrin-dependent signaling (56), and additional fac-
torsmay contribute, including clustering of ephrin ligands (57),
concentration of Eph receptors at the cell surface (58), and seg-
regation of ligands into discrete cell surface areas such as lipid
rafts (59). Although thesemolecularmodeling andmutagenesis
experiments enabled the identification of important interac-
tion domains of EphA3 and NCAM, crystal structures of the
receptor complex would confirm and extend knowledge of the
mechanism of oligomerization. Activation of RhoA down-
stream of EphA3/ephrin-A5 was found to be NCAM-depen-
dent and required for growth cone collapse. The observed col-
lapse of growth cones of axons and dendrites suggested that
NCAM/EphA3 signaling may regulate the retraction of both.
NCAMand EphA3 are enriched at perisomatic synapses in vivo
(2), supporting a role for this pathway in axons of basket
interneurons. Previous studies identified a mechanism of eph-
rinA-mediated RhoA activation through the guanine nucleo-
tide exchange factor Ephexin (60, 61), but this is the first study
to show that NCAM facilitates ephrin-A5-dependent activa-
tion of RhoA in cortical neurons. Selective inhibitors of RhoA
or its effector ROCK1/2 substantially decreased the collapse
response in GABAergic interneurons in culture. The residual
collapse observed inRhoAorROCK inhibitor-treated cells sug-
gested that other signaling effectors may contribute to the
repellent response. A limitation of this work is that long-term
(DIV 10–14) cortical neuron cultures were used to study
NCAM/EphA3 signaling important for growth cone collapse in
GABAergic neurons. Although growth cone collapse responses
in vitro correlate with inhibitory synapse densities observed in
vivo in WT and NCAM-null mice, the culture assay does not
distinguish ephrin-A5-induced growth cone repulsion from
elimination of nascent synapses. To address this question,
live imaging of perisomatic synapse formation and elimina-
tion in vivo in mice lacking NCAM and/or EphA3 would be
informative.
NCAM and ephrin-A5 are cleaved by EphA3-dependent
ADAM10 protease, a necessary step for growth cone collapse
(62–64). This study indicates that NCAM binding to EphA3
facilitates EphA3 receptor clustering and intracellular signaling
through RhoA/ROCK; thus, subsequent ADAM10-mediated
FIGURE 6.Model of NCAM clustering and activation of EphA3. Ephrin-A5 dimers bind the LBD domains of an EphA3 dimer. NCAMhomodimerizes through
Ig1-Ig2 interactions and clusters EphA3 receptors through binding to the EphA3 CRD. EphA3 clustering activates tyrosine kinase signaling through RhoA and
ROCK1/2, leading to axonal growth cone collapse. NCAM dimers are shown in black, and EphA3 dimers are shown inwhite.
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cleavage of NCAM may enable termini to retract from the
opposing cell or adhesive substrate. EphA3 kinase activity is
required for ADAM10-mediated NCAM cleavage (62); there-
fore, NCAM-mediated clustering and activation of EphA3 are
likely upstream of NCAM cleavage. Notably, the interaction
interfaces used by ADAM10 and NCAM for binding EphA3
are not overlapping. The EphA3 LBD interacts directly with
ADAM10 (64); thus, binding of NCAM to EphA3 may place
ADAM10 in a favorable conformation or optimal proximity to
cleave NCAM at perisomatic synapses that are eliminated dur-
ing development.
These findings support a mechanism in which NCAM stim-
ulates ephrin-A5-induced clustering of EphA3 receptors
through interactions of NCAMwith EphA3 receptors essential
for growth cone collapse through RhoA/ROCK activation in
cortical GABAergic interneurons (Fig. 6). As clustering of
EphA receptors is essential for downstream signaling at local-
ized sites in the neuronal membrane, the finding that NCAM
can enhance or stabilize the formation of EphA3 clusters
reveals an additional level of regulation in modulating growth
cone guidance. NCAM and EphA3 are both prominently
involved in development of the nervous system as well as in
some forms of cancer (46, 56, 65); therefore, understanding
how these two receptors interact functionally is relevant to both
normal development and disease states.
Experimental Procedures
Mice—The NCAM-null mutant (66, 67) and WT mice were
used according to the University of North Carolina Institu-
tional Animal Care and Use Committee policies and in accord-
ance with National Institutes of Health guidelines. All mice
were maintained on the C57BL/6 background.
Immunochemicals and Reagents—The monoclonal antibod-
ies used were anti-NCAM (OB11, Sigma-Aldrich), anti-phos-
photyrosine (Tyr(P)-99, Santa Cruz Biotechnology), anti-RhoA
(610990, BDTransduction Laboratories), anti-Cdc42 (MAb28-
10, a gift from Dr. Patrick Brennwald, University of North Car-
olina Chapel Hill (68)), and anti-Rac1 (102, BD Transduction
Laboratories). The polyclonal antibodies were EphA3 (C-19,
SantaCruzBiotechnology),NCAM(H300, SantaCruzBiotech-
nology), GABA (A2052, Sigma; ab17413, Abcam), and anti-
GFP (13970, Abcam). Normal rabbit IgG and goat anti-human
IgG were purchased from Jackson ImmunoResearch Laborato-
ries. Secondary antibodies purchased from Life Technologies
included anti-mouse Alexa 488, anti-mouse Alexa 555, anti-
mouse Alexa 647, anti-rabbit Alexa 555, and anti-rabbit Alexa
647. Other secondary antibodies used were anti-rabbit Alexa
405 (Abcam), anti-guinea pig Alexa 405 (Sigma-Aldrich), anti-
mouse-HRP (Pierce), and donkey anti-rabbit HRP (Sigma-Al-
drich). Recombinant ephrin-A5-Fc and human Fc (R&D Sys-
tems) were also used. Human NCAM-Fc proteins (69) were
purified from transfected HEK293T cell conditioned media
using Protein A-Sepharose (Pierce).
Modeling of NCAM/EphA3 Binding Site—The structure pre-
diction server HHpred (70, 71) identified the crystal structure
of the ectodomain of human EphA4 (PDB code 4M4P) (41), a
closely related homolog sharing 68% sequence identity with
mouse EphA3, as a template for predicting a structuralmodel of
the mouse EphA3 LBD and CRD domains. A model of the
EphA3 LBD and CRD domains was built using MODELLER
(72). The ClusPro protein-protein docking server (40, 73) was
used to predict potential interactions between EphA3 and
NCAM using the EphA3 CRD domain model and the Ig2
domain of rat NCAM from PDB code 1QZ1 (38), a crystal
structure of the ratNCAMIg1-Ig2-Ig3 domains. Docking poses
were screened for compatibility with interaction on the surface
of a membrane in a cis conformation, lack of steric hindrance
between additional domains of the molecules, and the number
of hydrogen bonds within the interaction interface. The top
candidate was analyzed for residues to mutate and assayed for
verification of the predicted interface.
Site-directed Mutagenesis—Mutations were made in the Ig2
domain of rat NCAM 140 (R192E, R156E, and K162D) in
pCDNA3 and in the cysteine-rich domain of mouse EphA3
(E248R and E264K). Deletion mutagenesis was used to delete
the Ig1 domain from NCAM Ig1–2-Fc cDNA while preserving
the signal peptide. All mutations were generated with the Q5
site-directed mutagenesis kit (E0554S, New England Biolabs).
The mutagenic primers were as follows: NCAM R192E, 5-
CTGTGAAGGCGAGATCCTGGCCC-3 and 5-CG GTAA-
GTGCCCTCATCTG-3; NCAM R156E, 5-ACACAAAGGC-
GAAGATGTCATCC-3 and 5-TTCCAGATGATGGTTGGG-
3; NCAM K162D, 5-CATCCTGAAAGACGATGTCCG-
GTTCAT AG-3 and 5-ACATCTCGGCCTTTGTGTTTC-
3; EphA3 E248R, 5-CACAGAAGGGAGATGG CTGG-
TCC-3 and 5-CTGCAGTACATCCTGGGA G-3; EphA3
E264K, 5-TGGGTATGAAAAA CGAGGTTTCATATG-3
and 5-GCATTGCAAGTGCATTTGC-3; andNCAMIg1-de-
letion, 5-GCCACCGTCAACGTGAAG-3 and 5-CAGGAA-
AAAC AAAGTCCAGATGAG-3.
Immunoprecipitation and Pulldown Assays—Proteins from
cell lysates (1mg) in radioimmunoprecipitation assay buffer (20
mM Tris (pH 7.0), 0.15 M NaCl, 5 mM EDTA, 1 mM EGTA, 1%
Nonidet P-40, 1% deoxycholate, 0.1% SDS, 200mNa3VO4, 10
mM NaF, and 1 protease inhibitor (Sigma)) were prepared as
described previously (74), and proteins were precipitated using
antibodies against EphA3 (C-19, Santa Cruz Biotechnology) or
NCAM (H-300, Santa Cruz Biotechnology), with protein A/G-
agarose beads (Thermo Fisher). For detection of EphA3 auto-
phosphorylation, WT and NCAM-null cells were treated with
preclustered ephrin-A5-Fc or control Fc (75) for 10 min and
then lysed in radioimmune precipitation assay buffer. EphA3
was immunoprecipitated, and tyrosine phosphorylation was
detected with anti-Tyr(P)-99. For coimmunoprecipitation of
EphA3 and NCAM140, HEK293T cells (DMEM, 10% fetal
bovine serum)were transfectedwith EphA3 andWTormutant
NCAM140 cDNA using Lipofectamine 2000 (Invitrogen). For
pulldown assays, HEK293T cells were transfected with WT
EphA3, EphA3LBD, or EphA3LBD/CRD. After 48 h, pro-
teins in cell lysates (500 g) were incubated with NCAM-Fc
proteins and proteinA/G-agarose beads to detect protein inter-
actions. Protein complexes were separated by SDS-PAGE,
immunoblotted using antibodies to EphA3, NCAM, or phos-
photyrosine, and detected with horseradish peroxidase-conju-
gated secondary antibodies.
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Immunostaining and Colocalization Analysis—For cortical
neuron cultures, embryonic day 0.5 (E0.5) was defined as the
plug date, and embryonic cultures were made at E15.5. Disso-
ciated cortical neurons from NCAM KO mice (E15.5) were
plated onto poly-D-lysine- and laminin-coated Lab-Tek II
chamber slides (1.5  105 cells/well) as described previously
(74, 76). At 10 DIV, NCAM KO neurons were co-transfected
with WT or mutant NCAM140 and pCAG-IRES-EGFP using
Lipofectamine 2000, and 48 h later, cells were stimulated with 1
g/ml preclustered Fc or ephrin-A5-Fc for 30 min. Cells were
fixed in 4% paraformaldehyde and blocked and permeabilized
in 10% horse serum and 0.5% Triton X-100/PBS. Slides were
incubated in primary antibodies (anti-NCAM, anti-EphA3, and
anti-GABA) overnight at 4 °C. Secondary antibodies (Alexa
405, Alexa 555, andAlexa 647) were added for 1 h andmounted
using SlowFade (Life Technologies). Confocal images were
obtained with Zeiss LSM700 and LSM710 microscopes using a
Plan-Apochromat 63 1.4 numerical aperture objective with
2 optical zoom using Zeiss Zen software. Only GFP/GABA
double-positive cells were imaged for analysis. Colocalization
of NCAM and EphA3 was analyzed using the ImageJ plugins
Colocalization_Test and Colocalization_Threshold by T. Col-
lins (Wright Cell Imaging Facility, Toronto Western Research
Institute, Toronto, ON, Canada) and W. Rasband (Research
Services Branch, NIMH, National Institutes of Health, Balti-
more, MD). Colocalization was expressed as three parameters:
R-coloc (the Pearson correlation coefficient, which varies
between	1 and 1) and thresholdedManders coefficients (tM1,
red channel, EphA3; tM2, green channel, NCAM), both of
which represent a fraction between 0 and 1. Each of these values
was calculated for pixels above a threshold level determined by
the regression algorithm contained in the Colocalization_
Threshold macro. For each condition, an average from mea-
surements of at least 45 images, in which individual GFP/
GABA-positive cells had been selected as regions of interest,
was reported. Images of colocalized pixels generated by the
Colocalization_Threshold plugin were converted to 8-bit
images, and the “Fire” lookup table of ImageJ was applied to
generate heat maps of colocalization.
RhoA, Rac1, and Cdc-42 GTPase Assays—Tomeasure RhoA,
Cdc42, and Rac1 activation, neurons fromWT or NCAM-null
E15.5 mice were cultured as described previously (76) for 10
days and then treated with preclustered Fc or ephrin-A5-Fc (1
g/ml) (75) for 30 min. The assay of Rac1 activity was per-
formed as described previously (77) with modifications. Cells
were first rinsed in chilled PBS and lysed in 50mMTris (pH 7.6),
150 mM NaCl, 1% Triton X-100, 0.5 mM MgCl2, and 1 prote-
ase inhibitor mixture (Sigma). GTP-bound activated Rac1 was
affinity-precipitated from cell lysates using an immobilized
GST fusion of the Rac1 binding domain of murine p65Pak (the
PBD) that binds Rac1-GTP but not Rac1-GDP (78). Rac1 that
sedimentedwith theGST-PBDbeadswas separated using SDS-
PAGE, transferred to a polyvinylidene difluoride membrane,
and blottedwith an antibody against Rac1. Cdc42-GTPbinds to
the same PBD construct (78), and so the same assay was used to
measure Cdc42 activity, except that the blots were probed with
an antibody against Cdc42 (MAb28–10) (68). Essentially the
same assay was used tomeasure RhoA-GTP, except the RBD of
Rhotekin (79) was used as the GST construct. RhoA that sedi-
mented with the GST-RBD beads was detected with an anti-
body against RhoA. The GST-PBD and GST-RBD beads were
kindly provided by the laboratory of Dr. Keith Burridge (Uni-
versity of North Carolina Chapel Hill).
Growth Cone Collapse Assay—Dissociated cortical neuron
cultures were generated from NCAM-null mice as described
above. At 10 DIV, WT or mutant NCAM140 plasmids were
transfected along with pCAG-IRES-EGFP using Lipofectamine
2000. After 48 h, cells were treated with preclustered ephrin-
A5-Fc or human Fc (1 g/ml) for 30 min and fixed, and growth
cones were visualized by immunofluorescence of staining for
GFP and GABA (2). Growth cones were scored as collapsed by
bullet-shaped morphology and non-collapsed by spread mor-
phology, and the percentage of collapsed growth cones of GFP/
GABA-positive neurons was compared (10 fields/well, 2
wells/experiment, 300 growth cones/condition). For Rho
inhibition, neuronswere pretreatedwith 1g/mlC3 (Cytoskel-
eton, Inc.) for 4 h prior to treatment with preclustered Fc or
ephrin-A5-Fc. For ROCK inhibition, neurons were pretreated
with 10 M Y-27632 for 2 h prior to stimulation with preclus-
tered ephrin-A5-Fc or control Fc.
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